Oxytocin
Drug40 IU; 5 puffs balanced across nostrils, at an inter-puff interval of 30 seconds
Other names: Syntocinon-Spray, Novartis
NCT Number: NCT03265899
The purpose of this study is to determine whether oxytocin modulates the processing of stress-associated chemosignals and which substrates are involved.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
Social transmission of stress and fear is not restricted to visual or auditory cues, but extends to the olfactory domain, a phylogenetically more ancient sense. Exposure to axillary sweat from healthy volunteers undergoing an emotional stressor task evokes a strong vicarious stress response on the behavioral and neural level.Particularly, anxious individuals have been shown to exhibit a heightened sensitivity to social chemosensory stress cues (axillary sweat). The neuropeptide oxytocin (OXT) exerts anxiolytic and anti-stress effects in visual and auditory modalities, however, it still elusive whether OXT also modulates the processing of stress-associated chemosignals. Axillary sweat were obtained from an unrelated sample of 30 healthy men undergoing the Trier Social Stress Test and ergometer training as control.Subsequently, subjects completed a forced-choice emotional face recognition task composed of stimuli with varying intensities (neutral to fearful), while they were exposed to both sweat stimuli and a non-social control odor (raspberry) after OXT or placebo administration, respectively. The investigators expect that OXT selectively diminishes chemosensory-induced behavioral biases and neural responses to stress-related odors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
40 IU; 5 puffs balanced across nostrils, at an inter-puff interval of 30 seconds
Other names: Syntocinon-Spray, Novartis
Placebo nasal spray, 5 puffs balanced across nostrils, at an inter-puff interval of 30 seconds
Other names: Placebo-Spray, Novartis
Time frame: 30 min after nasal spray administration
After each trial, subjects were asked to use a button response grip to indicate whether they perceived the depicted face as neutral or fearful.
Time frame: 30 min after nasal spray administration
Time frame: 30 minutes after nasal spray administration
The modulatory effect of oxytocin on neural correlates Using functional magnetic resonance imaging, signal changes in the amygdala, hippocampus and the anterior cingulate cortex in response to olfactory cues of stress and sport (axillary sweat obtained from an unrelated sample of 30 healthy men undergoing the Trier Social Stress Test and ergometer training as control).
Time frame: 15 minutes before the nasal spray administration and (on average) 10 minutes after the fMRI experiment
Time frame: immediately before the nasal spray administration and (on average) 10 minutes after the fMRI experiment
Time frame: 15 minutes after nasal spray administration and (on average) 10 minutes after the fMRI experiment
University Hospital, Bonn
Other
Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Stress-Associated Chemosignals Processing
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details